Your Twin learns with you

30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Allison Bernknopf

Professor

Ferris State University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (8)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Drug information specialists (DIS) bring unique, specialized expertise and provide services in diverse settings including health systems, academia, pharmaceutical industry, compendia, medical writing, and other areas. With widespread access to drug information (DI) resources through user‐friendly, online platforms, the role of DIS has shifted. Core skill sets once confined to DIS are now distributed across various non‐DIS clinical specialties. DIS have transformed the application of their specialized skill set and adapted it to a variety of traditional and nontraditional areas, providing and applying advanced expertise to solve a variety of contemporary challenges. The training of students and residents has evolved to include evidence‐based practical contemporary methods that promote critical thinking and reasoning. Effective DI evaluation and communication necessitates customizing content for stakeholders to ensure understanding and contribute to optimal patient care, all while addressing misinformation and disinformation. The future of DI as a specialty is bright, with ever‐increasing recognition of the importance of DI skills in non‐DIS practitioners. DIS will likely continue to guide best practices in the education/training of new practitioners and continue to provide advanced services and formulary analytics. This update to our 2009 DI PRN Opinion paper will focus on: (1) DI education and training needed for all students, residents, and pharmacists; (2) career opportunities, roles, and responsibilities specifically tailored for DIS in health systems, managed care organizations, academia, pharmaceutical/biotechnology industry, and medical writing services; and (3) the future direction of DI, including the potential impact of artificial intelligence.

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (11)

May H. Abdel Aziz

-

UNITED STATES
View details

Kristina E. Ward

University of Rhode Island

UNITED STATES
View details

Micheline Goldwire

Professor/Director of Drug Information Services

Regis University

UNITED STATES
View details

Taylor Thompson

Clinical Assistant Professor

West Virginia University

UNITED STATES
View details

Casey Rowe

Clinical Assistant Professor

University of Florida

UNITED STATES
View details

Karen Kier

Professor of Pharmacy Practice, Director of Drug and Health Information

Ohio Northern University

UNITED STATES
View details

Ellen Jones

Assistant Professor of Pharmacy Practice

Harding University

UNITED STATES
View details

Daniel Abazia

Clinical Associate Professor

Rutgers University

UNITED STATES
View details

Kyle Gustafson

Associate Professor

Northeast Ohio Medical University

UNITED STATES
View details

Jere May

Clinical Professor

University of Georgia

UNITED STATES
View details

Elizabeth Yett

Assistant Professor

University of Tennessee Health Science Center

UNITED STATES
View details